10.70
10.70 (0%)
As of Feb 14, 2025
Intellia Therapeutics Inc [NTLA]
Source:
Company Overview
Intellia Therapeutics, Inc. is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | ( 857 ) 285-6200 |
Industry | manufacturing |
CEO | John M. Leonard, M.D. |
Website | www.clinicaltrials.gov |